This document discusses type 1 diabetes mellitus. It describes the features of type 1 diabetes including its causes as pancreatic insufficiency resulting in insulin deficiency and its need for insulin treatment. The document outlines the signs and symptoms of type 1 diabetes such as polyuria, polydipsia, weight loss, fatigue and vision changes. It also discusses the laboratory tests used to diagnose type 1 diabetes including blood glucose, electrolytes and hemoglobin A1c levels.
Diabetes mellitus (DM) is a significant public health problem associated with many debilitating health conditions
This presentation will briefly tackle management of Diabetes
pathology and Complications of type 2 diabetes mellitusAiswarya Thomas
explains in detail abou various complications of diabetes mellitus and its pathophysiology. Described about the peripheral, microvascular, macrovascular comlpication
These slides content the explanation of what happen in Diabetes Melitus exactly. By learn how it could happen, may it be beneficial and help people in preventing the disease.
Diabetes mellitus (DM) is a significant public health problem associated with many debilitating health conditions
This presentation will briefly tackle management of Diabetes
pathology and Complications of type 2 diabetes mellitusAiswarya Thomas
explains in detail abou various complications of diabetes mellitus and its pathophysiology. Described about the peripheral, microvascular, macrovascular comlpication
These slides content the explanation of what happen in Diabetes Melitus exactly. By learn how it could happen, may it be beneficial and help people in preventing the disease.
COMPLICATIONS, MANAGEMENT AND TREATMENT APPROACH OF DIABETES MELLITUSAnas Indabawa
Diabetes describes a group of metabolic diseases in which the person has high blood glucose (blood sugar), either because insulin production is inadequate, or because the body's cells do not respond properly to insulin, or both. Mellitus is Latin for “sweet as honey”.
Pancreas is an elongated, tapered gland that is located behind the stomach and secretes digestive enzymes and the hormones insulin and glucagon.
The Pancreas secretes insulin and Glucagon directly into the blood stream.
It also secretes digestive enzymes into the pancreatic duct, which joins the common bile duct from the liver and drains into the small intestine.
Insulin and Glucagon have opposite effects on liver and other tissues for controlling blood-glucose levels.
Complications of Diabetes Mellitus & its Management.pptsaranpratha12
In diabetes mellitus (DM), years of poorly controlled hyperglycemia lead to multiple, primarily vascular, complications that affect small vessels (microvascular), large vessels (macrovascular) or both.
Immune dysfunction is another major complication and develops from the direct effects of hyperglycemia on cellular immunity.
DEFINITION OF DIABETES MELLITUS :
It is the group of metabolic disorders which characterised by hyperglycemia and abnormalities of carbohydrate, fat and protein metabolism. resulting from defects in insulin secretion, insulin action, or. Both .
Causes:-
Life style
Genetics factor
Obesity
Diet time variation
Etiological Classification of Diabetes:
Type :-1 Diabetes (insulin dependent)
Type :-2 Diabetes (non insulin dependent)
Gestational diabetes
DEFINTION OF TYPE 1 DIABETES :
Type 1 diabetes, once known as juvenile diabetes or insulin-dependent diabetes, is a chronic condition by the beta cells in islets of Langerhans in the pancreas in which the pancreas produces little or no insulin, due to the autoimmune destruction of the beta cells in the pancreas. Although onset frequently occurs in childhood, the disease can also develop in adults.
DEFINITION OF TYPE 2 DIABETES :
known as adult-onset diabetes, is a form of diabetes that is characterized by high blood sugar, due to body cells don’t respond normally to insulin; this is called insulin resistance.
DEFINITION OF GESTATIONAL DIABETES :
Gestational Diabetes: Is the increasing of blood sugar levels for Some women tend to experience high levels of blood glucose as during pregnancy due to reduced sensitivity of insulin receptors.
CAUSES :
The exact cause of type 1 diabetes is unknown. Usually, the body's own immune system — which normally fights harmful bacteria and viruses — mistakenly destroys cells which the insulin-producing (islets of Langerhans) cells in the pancreas. Other possible causes include:
Genetics
Exposure to viruses and other environmental factors
Endocrine disorders such as acromegaly , Cushing's syndrome
Endocrine disorders e.g. Pancreatitis .
Medications e.g. glucocorticoids , niacin , pentamine alpha- interferons .
Micro vascular complications (zeroplateas , neutrophils , eosinophil's )
Macro vascular complications (CHF , stroke , peripheral vascular disease)
SYMPTOMS :
Type 1 diabetes signs and symptoms can appear relatively suddenly and may include:
Increased thirst
Frequent urination
Bed-wetting in children who previously didn't wet the bed during the night
Extreme hunger
Unintended weight loss
Irritability and other mood changes
Fatigue and weakness
Blurred vision
PHARMACOLOGICAL TREATMENT :
Insulin:
People with type 1 diabetes must take insulin every day. You usually take the insulin through an injection.
Metformin :
Metformin is a type of oral diabetes medication. For many years, it was only used in people with type 2 diabetes. However, some people with type 1 diabetes can develop insulin resistance. That means the insulin they get from injections doesn’t work as well as it should.
Metformin helps lower sugar in the blood by reducing sugar production in the liver. Your doctor may advise you to take Metformin in addition to insulin.
B) NON- PHARMACOLOGICAL TREATMENT :
CONTROL THE SYMPTOMS .
EXERCISES
MONITORING THE SUGAR LEVELS
HEALTHY FOODS .
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
2. Diabetes Mellitus (Type I)
FEATURES:
– A chronic disease caused by pancreatic
insufficiency (deficiency) of insulin production,
resulting in hyperglycemia and end-organ
complications such as accelerated
atherosclerosis, neuropathy, nephropathy, and
retinopathy.
– Patients require insulin
– Response to oral drugs uncommon
3. Diabetes Mellitus (Type I)
FEATURES:
– Usually of rapid onset
– Nutritional status - normal or thin
– Disease lability
– Mean age of onset 8-12 years, peaking in
adolescence; onset about 1.5 years earlier in girls
than boys. Rapid decline in incidence after
adolescence.
– Prone to ketosis
4. Diabetes Mellitus (Type I)
SIGNS AND SYMPTOMS:
– Polyuria and polydipsia
– Polyphagia is classic, but not common
– Anorexia is commonly observed
– Weight loss (usually from 10-30%, and often almost
devoid of body fat at time of diagnosis)
– Increased fatigue
– Decreased energy levels and lethargy
– Muscle cramps
– Irritability and emotional lability
5. Diabetes Mellitus (Type I)
SIGNS AND SYMPTOMS:
– Vision changes, such as blurriness
– Altered school and work performance
– Headaches
– Anxiety attacks
– Chest pain and occasional difficult breathing
– Abdominal discomfort and pain
– Nausea
– Diarrhea or constipation
6. Diabetes Mellitus (Type I)
CAUSES:
– An inherited defect which causes an alteration in
immunologic integrity, placing the beta cell at risk
of inflammatory damage. The mechanism of
damage is autoimmune.
– Environmental factors include:
Viruses (such as mumps, Coxsackie, CMV, and hepatitis
viruses)
Dietary factors - breast feeding may provide a degree of
protection against the disease while diets high in dairy
products are associated with increased risk
Emotional and physical stress
7. Diabetes Mellitus (Type I)
LABORATORY:
– Blood glucose
– Electrolytes
– Venous pH
– U/A for glucose and ketones
– FBC (WBC may be elevated)
– Hemoglobin Alc level
8. Diabetes Mellitus (Type II)
DESCRIPTION:
1. Non-ketosis prone hyperglycemia and glucose
intolerance due to defects in insulin secretion and
peripheral insulin action. Accounts for 80% of
diabetic cases.
2. System (s) affected: Endocrine/Metabolic,
Nervous, Renal/Urologic, Cardiovascular
3. Predominant age: Typically occurs after age 40
4. Predominant sex: Female > Male in Caucasian
populations
9. Diabetes Mellitus (Type II)
SIGNS AND SYMPTOMS:
– Related to hyperglycemia and complications
including nephropathy, neuropathy, and
retinopathy
– Polyuria; Polydipsia; Polyphagia
– Weight loss
– Weakness
– Fatigue
– Frequent infections
10. Diabetes Mellitus (Type II)
CAUSES:
– Genetic factors and obesity are important
RISK FACTORS:
– Family history
– Gestational diabetes
– Obesity
11. Diabetes Mellitus (Type II)
POSSIBLE COMPLICATIONS:
Appear to be due to effects of diabetes
mellitus on arterial walls in one form or
another
– Peripheral neuropathy
– Proliferative retinopathy
– Nephropathy and chronic renal failure
– Atherosclerotic cardiovascular and peripheral
vascular disease
12. Diabetes Mellitus (Type II)
POSSIBLE COMPLICATIONS:
– Hyper-osmolar coma
– Gangrene of extremities
– Blindness
– Glaucoma
– Cataracts
– Skin ulceration
– Charcot joints
13. Diabetes Mellitus (Type II)
EXPECTED COURSE AND PROGNOSIS:
– Maintenance of normal blood sugar levels
may delay or prevent complications of
diabetes
– In susceptible individuals, complications
begin to appear 10-15 years after onset, but
can be present at time of diagnosis since
disease may go undetected for years
14. Diabetes Mellitus (Type II)
ASSOCIATED CONDITIONS:
– Hypertension is common (strict control
may retard renal complications)
– Hyperlipidaemia
– Impotence
15. The ocular manifestations
of DM
Eyelids Xanthelasmata
Conjunctiva Microaneurysms, venous dilatation
Extra-ocular muscles CN 3, 4 or 6 palsy with diplopia
Orbit Mucormycosis
Iris Rubeosis iridis (neovascularisation)
Glaucoma Neovasucular glaucoma
Pupil Poor dilatation caused by RI
Lens Cataract
Vitreous body Vitreous haemorrhage
Retina Diabetic retinopathy
Optic nerve Ischaemic papillitis, optic atrophy
16. DIABETIC RETINOPATHY
A sight-threatening chronic process based
primarily on damage to the retinal capillaries
(microangiopathy)
Later the process involves larger vessels:
venules, arterioles and arteries
A certain degree of retinopathy develops in
virtually every diabetic patient
23. Diabetes – Macular Edema
Affects 5-15% of
diabetic patients
Leakage into the
macula from small
capillaries
Results in severe
visual loss (e.g. no
useful reading
function)
25. Laboratory definition of
DM
Normal values
– Fasting (plasma): 3.6 to 6.4mmol/l
– Random (plasma): 3.3 to 7.4 mmol/l
– GTT: 7.9 to 11.0 mmol/l or fasting < 7.8
mmol/l
26. Laboratory definition of
DM
Indications for test
– The test is direct measurement of the
blood sugar and most commonly used in
the evaluation of diabetic patients
27. Laboratory definition of
DM
Clinical priorities
– Serum glucose levels must be evaluated according
to the time of day they are obtained. Increased
levels follow a recent meal.
– Glucose determinations must be performed
frequently in new diabetic patients to determine
appropriate insulin therapy. Finger prick blood
glucose are often performed before meals and at
bed time.
– Many forms of stress can cause increased serum
glucose levels.
– Many drugs affect glucose levels.
28. Interpretation of results
Interfering factors
– Acute stress (trauma, general anaesthesia,
infection, burns, myocardial infarction) increases
serum glucose levels.
– Caffeine may cause increased levels.
– IV fluids containing dextrose.
– Many pregnant women experience some degree of
glucose intolerance. If significant, it is called
gestational diabetes.
29. Interpretation of results
Interfering factors
– Drugs (antidepressants, beta-adrenergic blocking
agents, corticosteroids, IV dextrose infusion,
diuretics, phenothiazines, estrogens) increase
glucose levels.
– Drugs (acetaminophen, alcohol, anabolic
steroids, insulin and other anti-diabetics)
decrease glucose levels
– Pancreatic disease and endocrine disorders
30. Interpretation of results
A raised blood glucose is called hyperglycaemia.
When definite it is diagnostic of Diabetes Mellitus.
In an adult with symptoms, a random venous plasma
glucose of 11.1 mmol/l or more on two occasions or
a fasting value of 7.8 mmol/l or more on two
occasions is diagnostic.
Random values below 7.8 mmol/l and fasting values
below 6.4 mmol/l excludes a diagnosis of diabetes
mellitus.
32. Interpretation of results
A low blood glucose level is called
hypoglycaemia.
If less than 2.2 mmol/l it is
accompanied by symptoms such as
fainting, fits, sweating, hunger, pallor,
confusion or violence
33. Interpretation of results
Causes of hypoglycaemia
– Severe malnutrition
– Kwashiorkor
– Severe liver disease
– Alcoholic excess
– Insulin secreting tumours
– Addison’s disease
– Drugs
– Neonatal hypoglycaemia
– Malaria